The combined extract of Zingiber officinale and Zea mays (purple color) improves neuropathy, oxidative stress, and axon density in streptozotocin induced diabetic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Wattanathorn, Jintanaporn ^a   Thiraphatthanavong, Paphaphat ^b   Muchimapura, Supaporn ^a   Thukhammee, Wipawee ^a   Lertrat, Kamol ^b   Suriharn, Bhalang ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; GINGER EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; ZEA MAYS EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; LATENT PERIOD; MALE; NERVE CONDUCTION; NERVE FIBER; NERVE LESION; NEUROPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS;

EID: 84928752248     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/301029     Document Type: Article

References (42)

1. A. Gordois, P. Scuffham, A. Shearer, A. Oglesby, and J. A. Tobian, "Thehealth care costs of diabetic peripheral neuropathy in the U. S. , " Diabetes Care, vol. 26, no. 6, pp. 1790-1795, 2003.
2. R. E. Maser, A. R. Steenkiste, J. S. Dorman et al. , "Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh epidemiology of diabetes complications study, " Diabetes, vol. 38, no. 11, pp. 1456-1461, 1989.
3. M. J. Brown and A. K. Asbury, "Diabetic neuropathy, " Annals of Neurology, vol. 15, no. 1, pp. 2-12, 1984.
4. S. Thomson and L. Jacques, "Demographic characteristics of patients with severe neuropathic pain secondary to failed back surgery syndrome, " Pain Practice, vol. 9, no. 3, pp. 206-215, 2009.
5. C. E. Argoff, B. E. Cole, D. A. Fishbain, and G. A. Irving, "Diabetic peripheral neuropathic pain: clinical and quality-oflife issues, " Mayo Clinic Proceedings, vol. 81, no. 4, pp. S3-S11, 2006.
6. I. G. Obrosova, C. van Huysen, L. Fathallah, X. C. Cao, M. J. Stevens, and D. A. Greene, "An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense, " The FASEB Journal (Bethesda, MD), vol. 16, no. 1, pp. 123-125, 2002.
7. P. S. van Dam, "Oxidative stress and diabetic neuropathy: Pathophysiological mechanisms and treatment perspectives, " Diabetes/Metabolism Research and Reviews, vol. 18, no. 3, pp. 176-184, 2002.
8. A. M. Vincent, J. W. Russell, P. Low, and E. L. Feldman, "Oxidative stress in the pathogenesis of diabetic neuropathy, " Endocrine Reviews, vol. 25, no. 4, pp. 612-628, 2004.
9. S. S. M. Chung, E. C. M. Ho, K. S. L. Lam, and S. K. Chung, "Contribution of polyol pathway to diabetes-induced oxidative stress, " Journal of the American Society of Nephrology, vol. 14, supplement 3, pp. S233-S236, 2003.
10. Y. Li, V. H. Tran, C. C. Duke, and B. D. Roufogalis, "Preventive and protective properties of Zingiber officinale (Ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review, " Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 516870, 10 pages, 2012.
11. M. Y. Kang, S. S. Lim, J. Y. Lee, K. M. Yeo, and Y. H. Kang, "Anthocyanin-rich purple corn extract inhibit diabetesassociated glomerular angiogenesis, " PLoS ONE, vol. 8, no. 11, Article ID e79823, 2013.
12. P. Thiraphatthanavong, J. Wattanathorn, S. Muchimapura et al. , "Preventive effect of Zea mays L. (purple waxy corn) on experimental diabetic cataract, " BioMed Research International, vol. 2014, Article ID 507435, 8 pages, 2014.
13. P. Thiraphatthanavong, J. Wattanathorn, S. Muchimapura, W. Thukham-mee, K. Lertrat, and B. Suriharn, "The combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats, " Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID789406, 11 pages, 2014.
14. J. Khongrum, J. Wattanathorn, S. Muchimapura et al. , "Moringa oleifera leaves extract attenuates neuropathic pain induced by chronic constriction injury, " American Journal of Applied Sciences, vol. 9, no. 8, pp. 1182-1187, 2012.
15. G. J. Bennett and Y.-K. Xie, "A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man, " Pain, vol. 33, no. 1, pp. 87-107, 1988.
16. J. R. Bain, S. E. Mackinnon, and D. A. Hunter, "Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat, " Plastic and Reconstructive Surgery, vol. 83, no. 1, pp. 129-136, 1989.
17. L. de Medinaceli, W. J. Freed, and R. J. Wyatt, "An index of the functional condition of rat sciatic nerve based onmeasurements made fromwalking tracks, " Experimental Neurology, vol. 77, no. 3, pp. 634-643, 1982.
18. H. Hsu, N. Tang, Y. Lin, T. Li, H. Liu, and C. Hsieh, "Effect of electroacupuncture on rats with chronic constriction injuryinduced neuropathic pain, " The Scientific World Journal, vol. 2014, Article ID129875, 9 pages, 2014.
19. Y. Liu, L. Wang, X. Li, C. Lv, D. Feng, and Z. Luo, "Tanshinone IIAimproves impaired nerve functions in experimental diabetic rats, " Biochemical and Biophysical Research Communications, vol. 399, no. 1, pp. 49-54, 2010.
20. P. S. vanDam, B. Bravenboer, B. S. vanAsbeck, J. J. M. Marx, and W. H. Gispen, "High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats, " European Journal of Pharmacology, vol. 376, no. 3, pp. 217-222, 1999.
21. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, " Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
22. Y. Sun, L. W. Oberley, and Y. Li, "A simple method for clinical assay of superoxide dismutase, " Clinical Chemistry, vol. 34, no. 3, pp. 497-500, 1988.
23. L. Góth, "A simple method for determination of serum catalase activity and revision of reference range, " Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143-151, 1991.
24. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, "Selenium: biochemical role as a component of glatathione peroxidase, " Science, vol. 179, no. 4073, pp. 588-590, 1973.
25. M. B. Patel and S. M. Mishra, "Aldose reductase inhibitory activity and anticataract potential of some traditionally acclaimed antidiabetic medicinal plants, " Oriental Pharmacy and Experimental Medicine, vol. 9, no. 3, pp. 245-251, 2009.
26. M. S. Islam and D. T. Loots, "Experimental rodent models of type 2 diabetes: a review, "Methods and Findings in Experimental and Clinical Pharmacology, vol. 31, no. 4, pp. 249-261, 2009.
27. L. Wei, Y. Lu, S. He et al. , "Induction of diabetes with signs of autoimmunity in primates by the injection of multiplelow-dose streptozotocin, " Biochemical and Biophysical Research Communications, vol. 412, no. 2, pp. 373-378, 2011.
28. S. Lenzen, "The mechanisms of alloxan-and streptozotocininduced diabetes, " Diabetologia, vol. 51, no. 2, pp. 216-226, 2008.
29. Y. Wang, J. D. Schmelzer, A. Schmeichel, H. Iida, and P. A. Low, "Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy, " Journal of the Neurological Sciences, vol. 227, no. 1, pp. 101-107, 2004.
30. M. Dobretsov, D. Romanovsky, and J. R. Stimers, "Early diabetic neuropathy: triggers and mechanisms, " World Journal of Gastroenterology, vol. 13, no. 2, pp. 175-191, 2007.
31. G. Sundkvist, L.-B. Dahlin, H. Nilsson et al. , "Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance, " Diabetic Medicine, vol. 17, no. 4, pp. 259-268, 2000.
32. R. Courtemanche, N. Teasdale, P. Boucher, M. Fleury, Y. Lajoie, and C. Bard, "Gait problems in diabetic neuropathic patients, " Archives of Physical Medicine and Rehabilitation, vol. 77, no. 9, pp. 849-855, 1996.
33. C. Gooch and D. Podwall, "The diabetic neuropathies, " Neurologist, vol. 10, no. 6, pp. 311-322, 2004.
34. K. F. Eriksson, H. Nilsson, F. Lindgarde et al. , "Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves, " DiabeticMedicine, vol. 11, no. 3, pp. 279-285, 1994.
35. H. K. Kim, S. K. Park, J. L. Zhou et al. , "Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain, " Pain, vol. 111, no. 1-2, pp. 116-124, 2004.
36. Z.-Q. Wang, F. Porreca, S. Cuzzocrea et al. , "A newly identified role for superoxide in inflammatory pain, " Journal of Pharmacology and Experimental Therapeutics, vol. 309, no. 3, pp. 869-878, 2004.
37. M. Tal, "A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy, " NeuroReport, vol. 7, no. 8, pp. 1382-1384, 1996.
38. A. K. Naik, S. K. Tandan, S. P. Dudhgaonkar et al. , "Role of oxidative stress in pathophysiology of peripheral neuropathy and modulation by N-acetyl-l-cysteine in rats, " European Journal of Pain, vol. 10, no. 7, pp. 573-579, 2006.
39. A. Hosseini and M. Abdollahi, "Diabetic neuropathy and oxidative stress: therapeutic perspectives, " Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 168039, 15 pages, 2013.
40. L. Sivilotti and C. J. Woolf, "The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch?evoked allodynia in the spinal cord, " Journal of Neurophysiology, vol. 72, no. 1, pp. 169-179, 1994.
41. C.-O. Stiller, J.-G. Cui, W. T. O'Connor, E. Brodin, B. A. Meyerson, and B. Linderoth, "Release of aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats, " Neurosurgery, vol. 39, no. 2, pp. 367-375, 1996.
42. J. D. Goutman and D. J. Calvo, "Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABA 1 receptor, " British Journal of Pharmacology, vol. 141, no. 4, pp. 717-727, 2004.